Source: C2 Therapeutics Blog

C2 Therapeutics Blog PENTAX Medical Expands Interventional Endoscopy Offering with Acquisition of C2 Therapeutics

Press Release (U.S.A. version) - Outside U. S. A. version follows after U. S. A. version Montvale, NJ - January 9, 2017 - PENTAX Medical, a division of the HOYA Group, Tokyo, Japan announced today that they have acquired C2 Therapeutics, Redwood City, CA for an undisclosed amount. C2 Therapeutics develops the C2 CryoBalloon Ablation System [...]

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

President & CEO

Peter Garcia-Meza

CEO Approval Rating

69/100

Read more